NCT02141399

Brief Summary

This is a 52-week open-label study to evaluate the safety and tolerability of ALKS 5461.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,485

participants targeted

Target at P75+ for phase_3 major-depressive-disorder

Timeline
Completed

Started May 2014

Longer than P75 for phase_3 major-depressive-disorder

Geographic Reach
8 countries

158 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

May 15, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 19, 2014

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2017

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

December 14, 2018

Completed
Last Updated

December 14, 2018

Status Verified

November 1, 2018

Enrollment Period

3.6 years

First QC Date

May 15, 2014

Results QC Date

November 21, 2018

Last Update Submit

November 21, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Adverse Events (AEs)

    Up to 56 weeks

Study Arms (1)

ALKS 5461

EXPERIMENTAL
Drug: ALKS 5461

Interventions

Sublingual tablet, taken daily

ALKS 5461

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Agree to use an approved method of contraception for the duration of the study
  • Have the potential to safely benefit from the administration of ALKS 5461
  • Have a diagnosis of major depressive disorder (MDD)
  • Additional criteria may apply

You may not qualify if:

  • Have a positive test for drugs of abuse
  • Currently pregnant or breastfeeding
  • Have a current primary Axis-I disorder other than MDD
  • Have used opioid agonists (eg, codeine, oxycodone, tramadol, morphine) or opioid antagonists (eg, naloxone, naltrexone) within 14 days
  • Have received electroconvulsive therapy treatment within the last 2 years, or received more than 1 course of electroconvulsive treatment during their lifetime
  • Have attempted suicide within the past 2 years
  • Have a history of intolerance, allergy, or hypersensitivity to buprenorphine or opioid antagonists (eg, naltrexone, naloxone)
  • Have had a significant blood loss or blood donation within the past 60 days
  • Additional criteria may apply

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (158)

Alkermes Investigational Site

Birmingham, Alabama, 35226, United States

Location

Alkermes Investigational Site

Birmingham, Alabama, 35294, United States

Location

Alkermes Investigational Site

Tucson, Arizona, 85712, United States

Location

Alkermes Investigational Site

Little Rock, Arkansas, 72211, United States

Location

Alkermes Investigational Site

Bellflower, California, 90706, United States

Location

Alkermes Investigational Site

Beverly Hills, California, 90210, United States

Location

Alkermes Investigational Site

Carson, California, 90746, United States

Location

Alkermes Investigational Site

Garden Grove, California, 92845, United States

Location

Alkermes Investigational Site

Glendale, California, 91206, United States

Location

Alkermes Investigational Site

Los Alamitos, California, 90720, United States

Location

Alkermes Investigational Site

Los Angeles, California, 90024, United States

Location

Alkermes Investigational Site

National City, California, 91950, United States

Location

Alkermes Investigational Site

Oakland, California, 94612, United States

Location

Alkermes Investigational Site

Oceanside, California, 92056, United States

Location

Alkermes Investigational Site

Orange, California, 92868, United States

Location

Alkermes Investigational Site

Pico Rivera, California, 90660, United States

Location

Alkermes Investigational Site

Redlands, California, 92374, United States

Location

Alkermes Investigational Site

San Gabriel, California, 91776, United States

Location

Alkermes Investigational Site

Sherman Oaks, California, 91403, United States

Location

Alkermes Investigational Site

Temecula, California, 92591, United States

Location

Alkermes Investigational Site

Torrance, California, 90502, United States

Location

Alkermes Investigational Site

Upland, California, 91786, United States

Location

Alkermes Investigational Site

Colorado Springs, Colorado, 80910, United States

Location

Alkermes Investigational Site

Denver, Colorado, 80209, United States

Location

Alkermes Investigational Site

Hartford, Connecticut, 06106, United States

Location

Alkermes Investigational Site

Norwich, Connecticut, 06360, United States

Location

Alkermes Investigational Site

Bradenton, Florida, 34201, United States

Location

Alkermes Investigational Site

Coral Springs, Florida, 33067, United States

Location

Alkermes Investigational Site

Fort Myers, Florida, 33912, United States

Location

Alkermes Investigational Site

Gainesville, Florida, 32607, United States

Location

Alkermes Investigational Site

Hallandale, Florida, 33009, United States

Location

Alkermes Investigational Site

Hialeah, Florida, 33016, United States

Location

Alkermes Investigational Site

Jacksonville, Florida, 32256, United States

Location

Alkermes Investigational Site

Lauderhill, Florida, 33319, United States

Location

Alkermes Investigational Site

Maitland, Florida, 32751, United States

Location

Alkermes Investigational Site

Melbourne, Florida, 32901, United States

Location

Alkermes Investigational Site

North Miami, Florida, 33161, United States

Location

Alkermes Investigational Site

Oakland Park, Florida, 33334, United States

Location

Alkermes Investigational Site

Orlando, Florida, 32801, United States

Location

Alkermes Investigational Site

Tampa, Florida, 33613, United States

Location

Alkermes Investigational Site

The Villages, Florida, 32162, United States

Location

Alkermes Investigational Site

West Palm Beach, Florida, 33407, United States

Location

Alkermes Investigational Site

Winter Haven, Florida, 33880, United States

Location

Alkermes Investigational Site

Alpharetta, Georgia, 30005, United States

Location

Alkermes Investigational Site

Atlanta, Georgia, 30308, United States

Location

Alkermes Investigational Site

Decatur, Georgia, 30030, United States

Location

Alkermes Investigational Site

Smyrna, Georgia, 30080, United States

Location

Alkermes Investigational Site

Chicago, Illinois, 60634, United States

Location

Alkermes Investigational Site

Chicago, Illinois, 60640, United States

Location

Alkermes Investigational Site

Deerfield, Illinois, 60015, United States

Location

Alkermes Investigational Site

Hoffman Estates, Illinois, 60169, United States

Location

Alkermes Investigational Site

Joliet, Illinois, 60435, United States

Location

Alkermes Investigational Site

Oak Brook, Illinois, 60523, United States

Location

Alkermes Investigational Site

Skokie, Illinois, 60076, United States

Location

Alkermes Investigational Site

Indianapolis, Indiana, 46260, United States

Location

Alkermes Investigational Site

Lafayette, Indiana, 47905, United States

Location

Alkermes Investigational Site

Newburgh, Indiana, 47630, United States

Location

Alkermes Investigational Site

Valparaiso, Indiana, 46383, United States

Location

Alkermes Investigational Site

Edgewood, Kentucky, 41017, United States

Location

Alkermes Investigational Site

Owensboro, Kentucky, 42301, United States

Location

Alkermes Investigational Site

Baltimore, Maryland, 21204, United States

Location

Alkermes Investigational Site

Baltimore, Maryland, 21208, United States

Location

Alkermes Investigational Site

Washington D.C., Maryland, 20016, United States

Location

Alkermes Investigational Site

Belmont, Massachusetts, 02478, United States

Location

Alkermes Investigational Site

Brockton, Massachusetts, 02301, United States

Location

Alkermes Investigational Site

Watertown, Massachusetts, 02472, United States

Location

Alkermes Investigational Site

Worcester, Massachusetts, 01655, United States

Location

Alkermes Investigational Site

Flowood, Mississippi, 39232, United States

Location

Alkermes Investigational Site

O'Fallon, Missouri, 63368, United States

Location

Alkermes Investigational Site

Saint Charles, Missouri, 63304, United States

Location

Alkermes Investigational Site

St Louis, Missouri, 63109, United States

Location

Alkermes Investigational Site

St Louis, Missouri, 63141, United States

Location

Alkermes Investigational Site

Berlin, New Jersey, 80091, United States

Location

Alkermes Investigational Site

Cherry Hill, New Jersey, 08002, United States

Location

Alkermes Investigational Site

Princeton, New Jersey, 08540, United States

Location

Alkermes Investigational Site

Albuquerque, New Mexico, 87109, United States

Location

Alkermes Investigational Site

Brooklyn, New York, 11241, United States

Location

Alkermes Investigational Site

Jamaica, New York, 11432, United States

Location

Alkermes Investigational Site

Mount Kisco, New York, 10549, United States

Location

Alkermes Investigational Site

New York, New York, 10019, United States

Location

Alkermes Investigational Site

New York, New York, 10023, United States

Location

Alkermes Investigational Site

New York, New York, 10029, United States

Location

Alkermes Investigational Site

New York, New York, 10128, United States

Location

Alkermes Investigational Site

New York, New York, 10168, United States

Location

Alkermes Investigational Site

Staten Island, New York, 10305, United States

Location

Alkermes Investigational Site

Staten Island, New York, 10312, United States

Location

Alkermes Investigational Site

Charlotte, North Carolina, 28204, United States

Location

Alkermes Investigational Site

High Point, North Carolina, 27265, United States

Location

Alkermes Investigational Site

Beachwood, Ohio, 44122, United States

Location

Alkermes Investigational Site

Canton, Ohio, 44718, United States

Location

Alkermes Investigational Site

Cincinnati, Ohio, 45215, United States

Location

Alkermes Investigational Site

Cincinnati, Ohio, 45227, United States

Location

Alkermes Investigational Site

Dayton, Ohio, 45417, United States

Location

Alkermes Investigational Site

Mason, Ohio, 45040, United States

Location

Alkermes Investigational Site

Middleburg Heights, Ohio, 44130, United States

Location

Alkermes Investigational Site

Oklahoma City, Oklahoma, 73103, United States

Location

Alkermes Investigational Site

Oklahoma City, Oklahoma, 73112, United States

Location

Alkermes Investigational Site

Portland, Oregon, 97210, United States

Location

Alkermes Investigational Site

Portland, Oregon, 97214, United States

Location

Alkermes Investigational Site

Salem, Oregon, 97301, United States

Location

Alkermes Investigational Site

Allentown, Pennsylvania, 18104, United States

Location

Alkermes Investigational Site

Media, Pennsylvania, 19063, United States

Location

Alkermes Investigational Site

Philadelphia, Pennsylvania, 19104, United States

Location

Alkermes Investigational Site

Philadelphia, Pennsylvania, 19107, United States

Location

Alkermes Investigational Site

Lincoln, Rhode Island, 02865, United States

Location

Alkermes Investigational Site

Charleston, South Carolina, 29407, United States

Location

Alkermes Investigational Site

Memphis, Tennessee, 38119, United States

Location

Alkermes Investigational Site

Austin, Texas, 78731, United States

Location

Alkermes Investigational Site

Dallas, Texas, 75231, United States

Location

Alkermes Investigational Site

Dallas, Texas, 75390, United States

Location

Alkermes Investigational Site

DeSoto, Texas, 75115, United States

Location

Alkermes Investigational Site

Houston, Texas, 77081, United States

Location

Alkermes Investigational Site

Houston, Texas, 77098, United States

Location

Alkermes Investigational Site

San Antonio, Texas, 78229, United States

Location

Alkermes Investigational Site

Sugar Land, Texas, 77478, United States

Location

Alkermes Investigational Site

Wichita Falls, Texas, 76309, United States

Location

Alkermes Investigational Site

Clinton, Utah, 84015, United States

Location

Alkermes Investigational Site

Woodstock, Vermont, 05091, United States

Location

Alkermes Investigational Site

Bellevue, Washington, 98007, United States

Location

Alkermes Investigational Site

Seattle, Washington, 98104, United States

Location

Alkermes Investigational Site

Spokane, Washington, 99204, United States

Location

Alkermes Investigational Site

Middleton, Wisconsin, 53562, United States

Location

Alkermes Investigational Site

Waukesha, Wisconsin, 53188, United States

Location

Alkermes Investigational Site

Towong, Queensland, 4066, Australia

Location

Alkermes Investigational Site

Frankston, Victoria, 3199, Australia

Location

Alkermes Investigational Site

Melbourne, Victoria, 3004, Australia

Location

Alkermes Investigational Site

Burgas, 8001, Bulgaria

Location

Alkermes Investigational Site

Kazanlak, 6100, Bulgaria

Location

Alkermes Investigational Site

Sofia, 1113, Bulgaria

Location

Alkermes Investigational Site

Sofia, 1431, Bulgaria

Location

Alkermes Investigational Site

Sofia, 1632, Bulgaria

Location

Alkermes Investigational Site

Varna, 9020, Bulgaria

Location

Alkermes Investigational Site

Veliko Tarnovo, 5000, Bulgaria

Location

Alkermes Investigational Site

Vratsa, 3000, Bulgaria

Location

Alkermes Investigational Site

Penticton, British Columbia, V2A 4M4, Canada

Location

Alkermes Investigational Site

Halifax, Nova Scotia, B3S 1L8, Canada

Location

Alkermes Investigational Site

Gatineau, Quebec, J8T 8JL, Canada

Location

Alkermes Investigational Site

Québec, G3K 2P8, Canada

Location

Alkermes Investigational Site

Oranienburg, Brandenburg, 16515, Germany

Location

Alkermes Investigational Site

Achim, 28832, Germany

Location

Alkermes Investigational Site

Berlin, 10245, Germany

Location

Alkermes Investigational Site

Berlin, 10365, Germany

Location

Alkermes Investigational Site

Berlin, 10629, Germany

Location

Alkermes Investigational Site

Ellwangen, 73479, Germany

Location

Alkermes Investigational Site

Freiburg im Breisgau, 79104, Germany

Location

Alkermes Investigational Site

Hanover, 30159, Germany

Location

Alkermes Investigational Site

Mainz, 55131, Germany

Location

Alkermes Investigational Site

Schwerin, 19053, Germany

Location

Alkermes Investigational Site

Stralsund, 18439, Germany

Location

Alkermes Investigational Site

Budapest, 1053, Hungary

Location

Alkermes Investigational Site

Budapest, 1135, Hungary

Location

Alkermes Investigational Site

Budapest, 1137, Hungary

Location

Alkermes Investigational Site

Bialystok, 15-879, Poland

Location

Alkermes Investigational Site

Gdansk, 80-438, Poland

Location

Alkermes Investigational Site

Gdansk, 80-546, Poland

Location

Alkermes Investigational Site

Gorlice, 38-300, Poland

Location

Alkermes Investigational Site

San Juan, 00918, Puerto Rico

Location

Alkermes Investigational Site

San Juan, 00926, Puerto Rico

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Interventions

ALKS 5461

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Results Point of Contact

Title
Eva Stroynowski
Organization
Alkermes

Study Officials

  • Sanjeev Pathak, MD

    Alkermes, Inc.

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2014

First Posted

May 19, 2014

Study Start

May 1, 2014

Primary Completion

November 20, 2017

Study Completion

November 20, 2017

Last Updated

December 14, 2018

Results First Posted

December 14, 2018

Record last verified: 2018-11

Locations